NasdaqCM - Delayed Quote USD
RenovoRx, Inc. (RNXT)
0.9800
+0.0299
+(3.15%)
At close: April 23 at 4:00:00 PM EDT
0.9801
+0.00
+(0.01%)
After hours: April 23 at 6:59:05 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
8,118
1,466
7,265
16,287
Total Liabilities Net Minority Interest
3,640
4,466
1,102
938
Total Equity Gross Minority Interest
4,478
-3,000
6,163
15,349
Total Capitalization
4,478
-3,000
6,163
15,349
Common Stock Equity
4,478
-3,000
6,163
15,349
Capital Lease Obligations
278
--
--
--
Net Tangible Assets
4,478
-3,000
6,163
15,349
Working Capital
5,919
291
6,163
15,343
Invested Capital
4,478
-3,000
6,163
15,349
Tangible Book Value
4,478
-3,000
6,163
15,349
Total Debt
278
--
--
--
Share Issued
24,034.6720
10,693.5800
9,097.7010
8,933.9890
Ordinary Shares Number
24,034.6720
10,693.5800
9,097.7010
8,933.9890
12/31/2021 - 8/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ACTU Actuate Therapeutics, Inc. Common stock
9.00
+5.63%
NBY NovaBay Pharmaceuticals, Inc.
0.5772
-1.27%
RNTX Rein Therapeutics Inc.
1.8600
+0.54%
CUE Cue Biopharma, Inc.
0.8363
+6.85%
COYA Coya Therapeutics, Inc.
6.56
-1.20%
ABVC ABVC BioPharma, Inc.
0.8760
+5.35%
PROK ProKidney Corp.
0.9101
+21.49%
AVTE Aerovate Therapeutics, Inc.
2.7400
-0.72%
INAB IN8bio, Inc.
0.1825
+4.58%
APS.TO Aptose Biosciences Inc.
3.2500
-0.91%